| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 02/07/2002 | WO2002009647A2 Biological component comprising artificial membrane |
| 02/07/2002 | WO2002009644A2 Angiogenic and osteogenic proteins for use in enhancing bone density and formation |
| 02/07/2002 | WO2002009639A2 Methods and pharmaceutical compositions for healing wounds |
| 02/07/2002 | WO2002009514A1 Method of preserving cells and uses thereof |
| 02/07/2002 | WO2002009508A1 Nonhuman animal models non-responsive to mycoplasma-origin lipoprotein/lipopeptide |
| 02/07/2002 | WO2002009507A1 Somatic cloning gene transfer for the production of recombinant proteins, cells and organs |
| 02/07/2002 | WO2001075066A3 Dna molecules and polypeptides of pseudomonas syringae hrp pathogenicity island and their uses |
| 02/07/2002 | WO2001064238A3 Methods and compositions for regulating adipocytes |
| 02/07/2002 | WO2001059127A3 Drug metabolizing enzymes |
| 02/07/2002 | WO2001057193A3 Protein c derivatives |
| 02/07/2002 | WO2001055329A3 Nucleic acids, proteins, and antibodies |
| 02/07/2002 | WO2001055297A3 Three-dimensional matrix body, and device and method for measuring contractions of a cell tissue |
| 02/07/2002 | WO2001055211A3 Fil-1 theta dnas and polypeptides |
| 02/07/2002 | WO2001053469A3 Phosphatases |
| 02/07/2002 | WO2001053347A3 Nphs2 gene involved in the cortico-resistant neprhotic syndrome, protein encoded by said gene and diagnostic and therapeutic uses |
| 02/07/2002 | WO2001046388A3 Pathologically modified myocardial cell, production and use thereof |
| 02/07/2002 | WO2001042449A3 Methods for introducing genes into mammalian subjects |
| 02/07/2002 | WO2001040440A3 Maize mip synthase promoter |
| 02/07/2002 | WO2001034653A3 Protein present at the surface of hematopoietic stem cells of the lymphoid line and of nk cells, and uses thereof |
| 02/07/2002 | WO2001034206A3 Nucleic acid-containing complex |
| 02/07/2002 | WO2001032841A3 Method of in vitro t cell differentiation of cd34+ progenitor cells |
| 02/07/2002 | WO2001029255A9 Diagnostic test for cephalic pain |
| 02/07/2002 | WO2001029233A3 Chimeric immunogenic compositions and nucleic acids encoding them |
| 02/07/2002 | WO2001018216A3 26176, a novel calpain protease and uses thereof |
| 02/07/2002 | WO2001018050A9 T2r taste receptor family |
| 02/07/2002 | WO2001002587A3 Novel antifungal agents and fungicides, method for the production thereof and their use |
| 02/07/2002 | WO2001001150A3 Diagnostic test for thrombotic or thromboembolic disease |
| 02/07/2002 | WO2000068433A3 Autism gene |
| 02/07/2002 | WO2000068376A8 Novel chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |
| 02/07/2002 | US20020016978 Transgenic animal expressing non-native wild-type and familial alzheimer's disease mutant presenilin 1 protein on native presenilin 1 null background |
| 02/07/2002 | US20020016977 Method for production of a transgenic animal, and a transgenic animal produced by the method |
| 02/07/2002 | US20020016975 Nucletide sequences for use as tools in genetic engineering; for use in gene therapy |
| 02/07/2002 | US20020016445 Human monoclonal antibodies specific for hepatitis c virus (hcv) e2 antigen |
| 02/07/2002 | US20020016303 Genes which are differentially expressed in cardiovascular disease states, relative to their expression in normal, or non-cardiovascular disease states, and/or in response to manipulations relevant to cardiovascular disease. |
| 02/07/2002 | US20020016244 Method for separating cells, especially platelets, and bag assembly therefor |
| 02/07/2002 | US20020016003 Chemoselective ligation |
| 02/07/2002 | US20020016002 Multipotent neural stem cells from peripheral tissues and uses thereof |
| 02/07/2002 | US20020016000 Methods of isolating hepatic progenitors |
| 02/07/2002 | US20020015999 Decreasing toxic impurities from sample; expose sample to preferential air or gas, recover sample, monitor sample for impurities |
| 02/07/2002 | US20020015987 Peptide for use in the treatment of alzhiemer's, inflammation, cancer and immune defects |
| 02/07/2002 | US20020015983 Escherichia coli csrB gene, RNA encoded thereby, and methods of use thereof |
| 02/07/2002 | US20020015981 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 02/07/2002 | US20020015973 Detection of HLA-G |
| 02/07/2002 | US20020015950 Atherosclerosis-associated genes |
| 02/07/2002 | US20020015725 Wound healing agents |
| 02/07/2002 | US20020015704 Antibody, its binding portion or a probe is capable of binding to normal, benign, hyperplastic and cancerous epithelia cells and killing or ablating them; does not recognize antigens circulating in the blood |
| 02/07/2002 | US20020015700 Inhibiting the interaction of a cell bearing mammalian chemokine receptor 2 (CCR2) with a ligand by binding with antibodies or functional fragments |
| 02/07/2002 | US20020015696 Modulation of expression of nucleotide sequences encoding transcription factors; antidiabetic agents |
| 02/07/2002 | US20020015694 Hematopoietic differentiation of human embryonic stem cells |
| 02/07/2002 | DE10037101A1 Rekombinant hergestellte Enzyme mit verbesserter NAD(H)-Akzeptanz Recombinantly produced enzymes with improved NAD (H) -Akzeptanz |
| 02/07/2002 | DE10035433A1 Schonende Hochanreicherung von fetalen Zellen aus pripherem Blut und Verwendung derselben Gentle high enrichment of fetal cells from blood pripherem and using the same |
| 02/07/2002 | CA2778199A1 Alpha-amylase mutants with altered properties |
| 02/07/2002 | CA2419977A1 A novel assay for determination of androgenic or anti-androgenic activity of a serum sample or a test compound |
| 02/07/2002 | CA2418072A1 Insulin producing cell-line obtained by electrofusion |
| 02/07/2002 | CA2418052A1 Collagen membrane arranged at macromolecular level |
| 02/07/2002 | CA2417900A1 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | CA2417744A1 Model for alzheimer's disease and other neurodegenerative diseases |
| 02/07/2002 | CA2417719A1 Improved virus like particles based on small envelope protein from hepatitis b (hbsag-s) |
| 02/07/2002 | CA2417688A1 Tissue implant for cartilage repair |
| 02/07/2002 | CA2417671A1 Trp8, trp9 and trp10, novel markers for cancer |
| 02/07/2002 | CA2417612A1 C3b/c4b complement receptor-like molecules and uses thereof |
| 02/07/2002 | CA2417568A1 Growth differentiation factor receptors, agonists and antagonists thereof, and methods of using same |
| 02/07/2002 | CA2417359A1 Protein phosphatases |
| 02/07/2002 | CA2417356A1 Directed differentiation of embryonic cells |
| 02/07/2002 | CA2417349A1 Novel proteins and nucleic acids encoding same |
| 02/07/2002 | CA2417345A1 Method of cloning porcine animals |
| 02/07/2002 | CA2417278A1 Identification of a novel glutamine transporter |
| 02/07/2002 | CA2417271A1 Novel protein inhibitor of apoptosis proteins |
| 02/07/2002 | CA2417195A1 G-protein coupled receptors |
| 02/07/2002 | CA2417087A1 Mammalian dna binding membrane-associated protein-encoding gene and uses |
| 02/07/2002 | CA2416981A1 Synchronised arabidopsis cell suspensions and uses thereof |
| 02/07/2002 | CA2416967A1 Alpha-amylase mutants with altered properties |
| 02/07/2002 | CA2416893A1 Modified cea and uses thereof |
| 02/07/2002 | CA2416877A1 Somatic cloning gene transfer for producing recombinant proteins, cells and organs |
| 02/07/2002 | CA2416820A1 Isolated nucleic acid molecules which encode t cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 02/07/2002 | CA2416800A1 Isolation of drosophila and human polynucleotides encoding par-1 kinase, polypeptides encoded by the polynucleotides and methods utilizing the polynucleotides and polypeptides |
| 02/07/2002 | CA2416788A1 Methods and pharmaceutical compositions comprising protein kinase c isoforms for healing wounds |
| 02/07/2002 | CA2416732A1 Endothelial cell expression patterns |
| 02/07/2002 | CA2416710A1 Methods of controlling gene expression and gene silencing |
| 02/07/2002 | CA2415436A1 Metalloproteinase-disintegrin polypeptides and methods of making and use thereof |
| 02/07/2002 | CA2415433A1 A human disintegrin protein |
| 02/06/2002 | EP1178162A2 Sealing construction, in particular for drivable surfaces of car parks or similar |
| 02/06/2002 | EP1178116A1 Sid nucleic acids and polypeptides selected from a pathogenic strain of hepatitis C virus and applications thereof |
| 02/06/2002 | EP1178053A2 Polypeptides and polynucleotides coding therefor from a family of G-protein coupled receptors and their use for the diagnosis and treatment of skin diseases |
| 02/06/2002 | EP1177424A2 Multistage electromagnetic separator for purifying cells, chemicals and protein structures |
| 02/06/2002 | EP1177312A2 Human gil-19/ae289 proteins and polynucleotides encoding same |
| 02/06/2002 | EP1177304A2 Modified vitamin k-dependent polypeptides |
| 02/06/2002 | EP1177302A1 Gluconobacter suboxydans sorbitol dehydrogenase, genes and methods of use thereof |
| 02/06/2002 | EP1177301A2 $i(CHLAMYDIA) ANTIGENS AND CORRESPONDING DNA FRAGMENTS AND USES THEREOF |
| 02/06/2002 | EP1177298A1 Autotaxin variants and uses to treat diseases of metabolism |
| 02/06/2002 | EP1177297A2 Novel nucleic acids and proteins with growth hormone activity |
| 02/06/2002 | EP1177296A2 Extracellular matrix and adhesion-associated proteins |
| 02/06/2002 | EP1177294A1 Novel cellular regulation factor tto 20 |
| 02/06/2002 | EP1177293A1 Growth factor homolog zvegf4 |
| 02/06/2002 | EP1177292A2 Family of immunoregulators designated leukocyte immunoglobulin-like receptors (lir) |
| 02/06/2002 | EP1177291A2 Laminin 8 and methods for its use |
| 02/06/2002 | EP1177290A2 Recombinant laminin 5 |
| 02/06/2002 | EP1177287A2 Secreted human proteins |
| 02/06/2002 | EP1177286A1 Mdm interacting protein and methods of use thereof |
| 02/06/2002 | EP1177285A1 Chimpanzee erythropoietin (chepo) polypeptides and nucleic acids encoding the same |